Company
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.
Funding snapshot
- Total raised
- $105MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $55M2025-12-16
Funding rounds
- Round, 2025
- $55M2025-12-16, Company stated
- Round, 2024
- $50M2024-03-28, Company stated
Loading relationship preview